The rate of new PIM inhibitor discovery has increased significantly, and there has been demand for a new generation of potent molecules with the right pharmacologic profiles that can probably lead to the development of PIM kinase inhibitors that are effective against human cancer. Here, PIM1 is linked to cancer.